首页> 外文期刊>Life sciences >Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
【24h】

Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?

机译:完整的麻醉兔模型在急性缺血/再灌注过程中,肌膜或线粒体K(ATP)通道激活在抗心律失常和心脏保护作用中是否重要?

获取原文
获取原文并翻译 | 示例
       

摘要

The relative contributions of cardiomyocyte sarcolemmal ATP-sensitive K(+) (K(ATP)) and mitochondrial K(ATP) channels in the cardioprotection and antiarrhythmic activity induced by K(ATP) channel openers remain obscure, though the mitochondrial K(ATP) channels have been proposed to be involved as a subcellular mediator in cardioprotection afforded by ischemic preconditioning. In the present study, we sought to investigate the effects of administration of ATP-sensitive K(+) channel (K(ATP)) openers (nicorandil and minoxidil), a specific mitochondrial K(ATP) channel blocker (5-hydroxydecanoate (5-HD)) and a specific sarcolemmal K(ATP) channel blocker (HMR 1883; (1-[5-[2-(5-chloro-o-anisamido)ethyl]-2-methoxyphenyl]sulfonyl-3-methylthi ourea) prior to coronary occlusion as well as prior to post-ischemic reperfusion on survival rate, ischemia-induced and reperfusion-induced arrhythmias and myocardial infarct size in anesthetized albino rabbits. The thorax was opened in the left 4th intercostal space and after pericardiotomy the heart was exposed. In Group I (n=88), occlusion of the left main coronary artery and hence, myocardial ischemia-induced arrhythmias was achieved by tightening a previously placed loose silk ligature for 30 min. In Group II (n=206), arrhythmias were induced by reperfusion following a 20-min ligation of the left main coronary artery. Both in Group I and Group II, intravenous (i.v.) administration of nicorandil (0.47 mg/kg), minoxidil (0.5 mg/kg), HMR 1883 (3 mg/kg)icorandil and HMR 1883 (3 mg/kg)/minoxidil before coronary artery occlusion increased survival rate (86%, 75%, 75% and 86% vs. 55% in the control subgroup in Group I; 75%, 67%, 67% and 75% vs. 46% in the control subgroup in Group II), significantly decreased the incidence and severity of life-threatening arrhythmias. In Group II, i.v. administration of nicorandil and minoxidil before coronary artery occlusion significantly decreased myocardial infarct size. However, i.v. administration of nicorandil or minoxidil before reperfusion did neither increase survival rate nor confer any antiarrhythmic or cardioprotective effects. The antiarrhythmic and cardioprotective effects of both nicorandil and minoxidil were abolished by pretreating the rabbits with 5-HD (5 mg/kg, i.v. bolus), a selective mitochondrial K(ATP) channel blocker but not by HMR 1883 (3 mg/kg). In the present study, higher levels of malondialdehyde (MDA) and lower levels of reduced glutathione (GSH) and superoxide dismutase (SOD) in necrotic zone of myocardium in all the 16 subgroups in Group II suggest little anti-free radical property of nicorandil and minoxidil. We conclude that intervention by intravenous administration of nicorandil and minoxidil (through the selective activation of mitochondrial K(ATP) channels) increased survival rate and exhibited antiarrhythmic and cardioprotective effects during coronary occlusion and reperfusion in anesthetized rabbits when administered prior to coronary occlusion. The cardiomyocyte mitochondrial K(ATP) channel may be apharmacologically modulable target of cardioprotection and antiarrhythmic activity.
机译:尽管线粒体K(ATP)可以使心肌细胞肌膜ATP敏感性K(+)(K(ATP))和线粒体K(ATP)通道在由K(ATP)通道开放剂诱导的心脏保护和抗心律不齐活动中的相对贡献仍然不清楚有人提出将这些通道作为亚细胞介体参与缺血预处理提供的心脏保护作用。在本研究中,我们试图研究ATP敏感的K(+)通道(K(ATP))开放剂(尼可地尔和米诺地尔),特定的线粒体K(ATP)通道阻滞剂(5-羟基癸酸酯(5 -HD))和特定的肌膜K(ATP)通道阻滞剂(HMR 1883;(1- [5- [2-(5-氯-邻-氨基-氨基)乙基] -2-甲氧基苯基]磺酰基-3-甲基噻吩)麻醉的白化病兔在冠状动脉闭塞前,缺血再灌注前的生存率,缺血性和再灌注性心律失常及心肌梗死面积,在左侧第4肋间隙开胸,进行心脏切开术在第一组(n = 88),左主冠状动脉闭塞,因此,心肌缺血引起的心律不齐是通过拉紧先前放置的松散的丝结扎30分钟来实现的;在第二组(n = 206),是心律不齐结扎左主冠状动脉20分钟后通过再灌注诱导在第I组和第II组中,静脉内(iv)施用尼可地尔(0.47 mg / kg),米诺地尔(0.5 mg / kg),HMR 1883(3 mg / kg)/尼可地尔和HMR 1883(3 mg / kg)/米诺地尔冠状动脉闭塞前生存率增加(I组对照组为86%,75%,75%和86%,而对照组为55%;组II中的对照组亚组的75%,67%,67%和75%与46%相比,显着降低了危及生命的心律不齐的发生率和严重程度。在第二组中在冠状动脉闭塞前给予尼可地尔和米诺地尔显着降低了心肌梗塞面积。但是,i.v。再灌注前给予尼可地尔或米诺地尔既不能提高生存率,也不会产生任何抗心律失常或心脏保护作用。尼可地尔和米诺地尔的抗心律失常和心脏保护作用通过用5-HD(5 mg / kg,静脉推注),选择性线粒体K(ATP)通道阻断剂预处理兔子而取消,但未通过HMR 1883(3 mg / kg)预处理。在本研究中,II组所有16个亚组的心肌坏死区的丙二醛(MDA)含量较高,还原型谷胱甘肽(GSH)和超氧化物歧化酶(SOD)含量较低,提示尼可地尔和米诺地尔。我们得出的结论是,通过静脉内施用尼可地尔和米诺地尔(通过线粒体K(ATP)通道的选择性激活)进行干预可以提高生存率,并在冠状动脉阻塞和冠状动脉阻塞之前的再灌注过程中表现出抗心律失常和心脏保护作用。心肌线粒体K(ATP)通道可能是心脏保护和抗心律失常活性的药理可调节靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号